Search - tctmd.com

Displaying 301 - 320 of 378

Sort: Relevancy | Date

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

News Daily News

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

Yael L. Maxwell

April 18, 2024

New Heart Failure After AF Diagnosis Merits More Attention

News Daily News

New Heart Failure After AF Diagnosis Merits More Attention

April 18, 2024

INOCA May Be at the Root of Angina for Many Long-COVID Patients

News Daily News

INOCA May Be at the Root of Angina for Many Long-COVID Patients

April 17, 2024

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter

News Conference News EHRA 2024

Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter

April 16, 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

News Conference News ACC 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

April 16, 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

April 15, 2024

LAA Closure, PFO Closure, and Other Novel Structural Heart Procedures

Presentation Fellows 2024

LAA Closure, PFO Closure, and Other Novel Structural Heart Procedures

Presenter: Vivian G. Ng

April 13, 2024

Ultralow-Temperature Cryoablation Promising for Monomorphic VT

News Conference News EHRA 2024

Ultralow-Temperature Cryoablation Promising for Monomorphic VT

April 12, 2024

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

News Daily News

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

April 12, 2024

Telemedicine Strategy After MI Scores a Win in TELE-ACS

News Conference News ACC 2024

Telemedicine Strategy After MI Scores a Win in TELE-ACS

April 12, 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

News Conference News ACC 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

Yael L. Maxwell

April 09, 2024

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

Presentation ACC 2024

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

Presenter: Martin S. Maron

April 08, 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

April 06, 2024

TCTMD’s Top 10 Most Popular Stories for March 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

April 03, 2024

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

News Industry News

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

April 03, 2024

April 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

April 01, 2024

What’s Going to Be Hot at ACC 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

April 01, 2024

Evoque and Patisiran: A Tale of Two Regulatory Journeys

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

ACC Chest Pain Pathway Performs Well Overall, Less So for Those With CAD

News Daily News

ACC Chest Pain Pathway Performs Well Overall, Less So for Those With CAD

Yael L. Maxwell

March 28, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.